Loading...
XHELTTALO
Market cap1.37bUSD
Dec 20, Last price  
10.38EUR
1D
0.39%
1Q
9.96%
IPO
2.17%
Name

Terveystalo Oyj

Chart & Performance

D1W1MN
XHEL:TTALO chart
P/E
—
P/S
1.02
EPS
—
Div Yield, %
2.69%
Shrs. gr., 5y
-0.19%
Rev. gr., 5y
11.55%
Revenues
1.29b
+2.17%
474,125,000505,619,000546,964,000689,500,000744,700,0001,030,700,000986,400,0001,154,600,0001,259,100,0001,286,400,000
Net income
-42m
L
-82,897,0001,105,00012,606,0007,200,00068,700,00054,100,00045,800,00080,500,00024,400,000-42,200,000
CFO
158m
+12.14%
58,303,00059,932,00064,670,00070,000,000100,600,000173,600,000143,700,000195,200,000140,900,000158,000,000
Dividend
Oct 08, 20240.15 EUR/sh
Earnings
Feb 12, 2025

Profile

Terveystalo Oyj provides occupational healthcare services in Finland. The company offers general practice and specialist medical care, diagnostic, outpatient surgery, dental, and other adjacent services; and outsourcing services, staffing services, child welfare services, oral health, laboratory, imaging, wellbeing, day surgery, healthcare outsourcing, healthcare staffing, and primary and specialty care services. It also provides a suite of digital healthcare services; and clinical research services. The company serves private individuals, companies and communities, insurance companies, and public sector customers. It operates 360 clinics, which include 18 hospital units and 38 dental clinics; and 73 Rela hierojat massage therapy units. The company was founded in 2001 and is based in Helsinki, Finland.
URL
https://www.terveystalo.com/
IPO date
Oct 11, 2017
Employees
10,094
Domiciled in
FI
Incorporated in
FI

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,286,400
2.17%
1,259,100
9.05%
1,154,600
17.05%
Cost of revenue
1,004,100
542,000
498,700
Unusual Expense (Income)
NOPBT
282,300
717,100
655,900
NOPBT Margin
21.94%
56.95%
56.81%
Operating Taxes
3,300
6,500
20,300
Tax Rate
1.17%
0.91%
3.09%
NOPAT
279,000
710,600
635,600
Net income
(42,200)
-272.95%
24,400
-69.69%
80,500
75.76%
Dividends
(35,400)
(35,400)
(33,100)
Dividend yield
3.59%
4.46%
2.19%
Proceeds from repurchase of equity
8,100
BB yield
-0.54%
Debt
Debt current
68,800
90,700
168,000
Long-term debt
789,900
704,100
581,200
Deferred revenue
8,800
10,300
6,100
Other long-term liabilities
7,800
24,400
23,800
Net debt
821,000
753,000
709,900
Cash flow
Cash from operating activities
158,000
140,900
195,200
CAPEX
(24,600)
(59,200)
(43,100)
Cash from investing activities
(44,200)
(93,900)
(108,000)
Cash from financing activities
(116,200)
(44,600)
(126,100)
FCF
247,300
674,700
682,100
Balance
Cash
37,700
40,200
38,100
Long term investments
1,600
1,200
Excess cash
Stockholders' equity
531,100
607,800
626,900
Invested Capital
1,167,800
1,209,700
1,162,000
ROIC
23.47%
59.92%
56.32%
ROCE
23.76%
57.87%
55.09%
EV
Common stock shares outstanding
127,037
127,037
127,700
Price
7.77
24.32%
6.25
-47.21%
11.84
17.93%
Market cap
987,077
24.32%
793,981
-47.49%
1,511,968
17.78%
EV
1,808,077
1,546,981
2,221,868
EBITDA
389,200
852,000
747,600
EV/EBITDA
4.65
1.82
2.97
Interest
23,500
9,800
9,400
Interest/NOPBT
8.32%
1.37%
1.43%